Showing 1 - 20 results of 46 for search 'Randall J. Bateman', query time: 0.07s Refine Results
  1. 1
    Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease

    Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzh... by Nicolas R. Barthélemy, Nipun Mallipeddi, Paul Moiseyev, Chihiro Sato, Randall J. Bateman, Randall J. Bateman, Randall J. Bateman

    Published 2019-05-01
    Get full text
    Article
  2. 2
    Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias

    Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias by Nikolay V. Dokholyan, Richard C. Mohs, Randall J. Bateman

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Diurnal oscillation of CSF Aβ and other AD biomarkers

    Diurnal oscillation of CSF Aβ and other AD biomarkers by Brendan P. Lucey, Anne M. Fagan, David M. Holtzman, John C. Morris, Randall J. Bateman

    Published 2017-05-01
    Get full text
    Article
  4. 4
    Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

    Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification by Nicolas R. Barthélemy, Randall J. Bateman, Christophe Hirtz, Philippe Marin, François Becher, Chihiro Sato, Audrey Gabelle, Sylvain Lehmann

    Published 2020-03-01
    Get full text
    Article
  5. 5
    The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method

    The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method by Justyna A. Dobrowolska Zakaria, Randall J. Bateman, Monika Lysakowska, Ammaarah Khatri, Dinorah Jean-Gilles, Matthew E. Kennedy, Robert Vassar

    Published 2022-09-01
    Get full text
    Article
  6. 6
    Amyloid-β Plaques in Clinical Alzheimer’s Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity

    Amyloid-β Plaques in Clinical Alzheimer’s Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity by Norelle C. Wildburger, Frank Gyngard, Christelle Guillermier, Christelle Guillermier, Christelle Guillermier, Bruce W. Patterson, Donald Elbert, Kwasi G. Mawuenyega, Theresa Schneider, Karen Green, Robyn Roth, Robyn Roth, Robert E. Schmidt, Nigel J. Cairns, Nigel J. Cairns, Nigel J. Cairns, Nigel J. Cairns, Tammie L. S. Benzinger, Tammie L. S. Benzinger, Tammie L. S. Benzinger, Matthew L. Steinhauser, Matthew L. Steinhauser, Matthew L. Steinhauser, Randall J. Bateman, Randall J. Bateman, Randall J. Bateman

    Published 2018-03-01
    Get full text
    Article
  7. 7
    Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype

    Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype by Huifangjie Li, William C. Knight, Pengfei Yang, Yingqiu Guo, Joel S. Perlmutter, John C. Morris, Randall J. Bateman, Tammie L. S. Benzinger, Jinbin Xu

    Published 2020-08-01
    Get full text
    Article
  8. 8
    Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease

    Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease by Guoqiao Wang, Lei Liu, Yan Li, Andrew J. Aschenbrenner, Randall J. Bateman, Paul Delmar, Lon S. Schneider, Richard E. Kennedy, Gary R. Cutter, Chengjie Xiong

    Published 2022-01-01
    Get full text
    Article
  9. 9
    Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults

    Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults by Lingxiao He, Philipe de Souto Barreto, Geetika Aggarwal, Andrew D. Nguyen, John E. Morley, Yan Li, Randall J. Bateman, Bruno Vellas, For the MAPT/DSA Group

    Published 2020-10-01
    Get full text
    Article
  10. 10
    Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

    Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 pro... by Eric McDade, Jeffrey L. Cummings, Shobha Dhadda, Chad J. Swanson, Larisa Reyderman, Michio Kanekiyo, Akihiko Koyama, Michael Irizarry, Lynn D. Kramer, Randall J. Bateman

    Published 2022-12-01
    Get full text
    Article
  11. 11
    Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction

    Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction by Lubov A. Ezerskiy, Kathleen M. Schoch, Chihiro Sato, Mariana Beltcheva, Kanta Horie, Frank Rigo, Ryan Martynowicz, Celeste M. Karch, Randall J. Bateman, Timothy M. Miller

    Published 2022-01-01
    Get full text
    Article
  12. 12
    Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

    Plasma MCP-1 and changes on cognitive function in community-dwelling older adults by Juan Luis Sanchez-Sanchez, Kelly V. Giudici, Sophie Guyonnet, Julien Delrieu, Yan Li, Randall J. Bateman, Angelo Parini, Bruno Vellas, Philipe de Souto Barreto, for the MAPT/DSA Group

    Published 2022-01-01
    Get full text
    Article
  13. 13
    MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

    MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology by Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Albert H. Kim, Gregory J. Zipfel, Randall J. Bateman, Audrey Gabelle, Nicolas R. Barthélemy

    Published 2021-09-01
    Get full text
    Article
  14. 14
    Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

    Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau by Niklas Mattsson‐Carlgren, Shorena Janelidze, Randall J Bateman, Ruben Smith, Erik Stomrud, Geidy E Serrano, Eric M Reiman, Sebastian Palmqvist, Jeffrey L Dage, Thomas G Beach, Oskar Hansson

    Published 2021-06-01
    Get full text
    Article
  15. 15
    Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease

    Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease by Randall J. Bateman, Jeffrey Cummings, Scott Schobel, Stephen Salloway, Bruno Vellas, Mercè Boada, Sandra E. Black, Kaj Blennow, Paulo Fontoura, Gregory Klein, Sheila Seleri Assunção, Janice Smith, Rachelle S. Doody

    Published 2022-11-01
    Get full text
    Article
  16. 16
    The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review

    The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review by Abby L. Brand, Paige E. Lawler, James G. Bollinger, Yan Li, Suzanne E. Schindler, Melody Li, Samir Lopez, Vitaliy Ovod, Akinori Nakamura, Leslie M. Shaw, Henrik Zetterberg, Oskar Hansson, Randall J. Bateman

    Published 2022-12-01
    Get full text
    Article
  17. 17
    Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology

    Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology by Daniel J. Figdore, Heather J. Wiste, Joshua A. Bornhorst, Randall J. Bateman, Yan Li, Jonathan Graff‐Radford, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack Jr, Ronald C. Petersen, Alicia Algeciras‐Schimnich

    Published 2024-01-01
    Get full text
    Article
  18. 18
    Comparison of plasma and CSF biomarkers in predicting cognitive decline

    Comparison of plasma and CSF biomarkers in predicting cognitive decline by Andrew J. Aschenbrenner, Yan Li, Rachel L. Henson, Katherine Volluz, Jason Hassenstab, Philip Verghese, Tim West, Matthew R. Meyer, Kristopher M. Kirmess, Anne M. Fagan, Chengjie Xiong, David Holtzman, John C. Morris, Randall J. Bateman, Suzanne E. Schindler

    Published 2022-11-01
    Get full text
    Article
  19. 19
    Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques

    Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques by Shveta Bathla, Dibyadeep Datta, Feng Liang, Nicolas Barthelemy, Robyn Wiseman, Barbara S Slusher, Jennifer Asher, Caroline Zeiss, Dil Ekanayake‐Alper, Daniel Holden, Gordon Terwilliger, Alvaro Duque, Jon Arellano, Christopher van Dyck, Randall J. Bateman, Zhongcong Xie, Angus C. Nairn, Amy F. T. Arnsten

    Published 2023-10-01
    Get full text
    Article
  20. 20
    A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

    A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysi... by Tim West, Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch, Stephanie S. Knapik, Yan Hu, John H. Contois, Erin N. Jackson, Scott E. Harpstrite, Randall J. Bateman, David M. Holtzman, Philip B. Verghese, Ilana Fogelman, Joel B. Braunstein, Kevin E. Yarasheski

    Published 2021-05-01
    Get full text
    Article

Search Tools: